Polymyositis/dermatomyositis and interstitial lung disease: A new therapeutic approach with T-cell-specific immunosuppressants

References

• Mills ES, Mathews WH. Interstitial pneumonitis in dermatomyositis. J Am Med Assoc 1956; 160: 1467–1470
   PubMed Web of Science ®Google Scholar
• Dickey BF, Myers AR. Pulmonary disease in polymyositis/dermatomyositis. Semin Arthritis Rheum 1984; 14: 60–76
   PubMed Web of Science ®Google Scholar
• Frazier AR, Miller RD. Interstitial pneumonitis in association with polymyositis and dermatomyositis. Chest 1974; 65: 403–407
   PubMed Web of Science ®Google Scholar
• Salmeron G, Greenberg SD, Lidsky MD. Polymyositis and diffuse interstitial lung disease: A review of the pulmonary histopathologic findings. Arch Intern Med 1981; 141: 1005–1010
   PubMedGoogle Scholar
• Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV. Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990; 141: 727–733
   PubMed Web of Science ®Google Scholar
• Grau JM, Miro O, Pedrol E, Casademont J, Masanes F, Herrero C, et al. Interstitial lung disease related to dermatomyositis: Comparative study with patients without lung involvement. J Rheumatol 1996; 23: 1921–1926
   PubMed Web of Science ®Google Scholar
• Marie I, Hatron PY, Hachulla E, Wallaert B, Michon-Pasturel U, Devulder B. Pulmonary involvement in polymyositis and in dermatomyositis. J Rheumatol 1998; 25: 1336–1343
   PubMed Web of Science ®Google Scholar
• Hirakata M, Nakamura K, Kaburaki J, Suwa A, Mimori T, Kanazawa M, et al. Interstitial lung disease in patients with connective tissue diseases. Nihon Kyobu Shikkan Gakkai Zasshi 1995, 33 Suppl.: 268–276
   PubMedGoogle Scholar
• Hochberg MC, Feldman D, Stevens MB, Arnett FC, Reichlin M. Antibody to Jo-1 in polymyositis/dermatomyositis: Association with interstitial pulmonary disease. J Rheumatol 1984; 11: 663–665
   PubMed Web of Science ®Google Scholar
• Targoff IN, Trieu EP, Plotz PH, Miller FW. Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease. Arthritis Rheum 1992; 35: 821–830
   PubMed Web of Science ®Google Scholar
• Targoff IN, Arnett FC. Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). Am J Med 1990; 88: 241–251
   PubMed Web of Science ®Google Scholar
• Marguerie C, Bunn CC, Beynon HL, Bernstein RM, Hughes JM, So AK, et al. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 1990; 77: 1019–1038
   PubMedGoogle Scholar
• American Thoracic Society and European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002; 165: 277–304
   PubMedGoogle Scholar
• Douglas WW, Tazelaar HD, Hartman TE, Hartman RP, Decker PA, Schroeder DR, et al. Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 2001; 164: 1182–1185
   PubMed Web of Science ®Google Scholar
• Akira M, Hara H, Sakatani M. Interstitial lung disease in association with polymyositis-dermatomyositis: Long-term follow-up CT evaluation in seven patients. Radiology 1999; 210: 333–338
   PubMed Web of Science ®Google Scholar
• Lakhanpal S, Lie JT, Conn DL, Martin WJ. Pulmonary disease in polymyositis/dermatomyositis: A clinicopathological analysis of 65 autopsy cases. Ann Rheum Dis 1987; 46: 23–29
   PubMed Web of Science ®Google Scholar
• Lee CS, Chen TL, Tzen CY, Lin FJ, Peng MJ, Wu CL, et al. Idiopathic inflammatory myopathy with diffuse alveolar damage. Clin Rheumatol 2002; 21: 391–396
   PubMed Web of Science ®Google Scholar
• Ito M, Kaise S, Suzuki S, Kazuta Y, Sato Y, Miyata M, et al. Clinico-laboratory characteristics of patients with dermatomyositis accompanied by rapidly progressive interstitial lung disease. Clin Rheumatol 1999; 18: 462–467
   PubMed Web of Science ®Google Scholar
• Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994; 18: 136–147
   PubMed Web of Science ®Google Scholar
• Nicholson AG, Colby TV, du Bois RM, Hansell DM, Wells AY. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 2000; 162: 2213–2217
   PubMed Web of Science ®Google Scholar
• Bjoraker JA, Ryu JH, Edwin MK, Myers JL, Tazelaar HD, Schroeder DR, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 157: 199–203
   PubMed Web of Science ®Google Scholar
• Nagai S, Kitaichi M, Itoh H, Nishimura K, Izumi T, Colby TV. Idiopathic nonspecific interstitial pneumonia/fibrosis: Comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 1998; 12: 1010–1019
   PubMed Web of Science ®Google Scholar
• Travis WD, Matsui K, Moss J, Ferrans VJ. Idiopathic nonspecific interstitial pneumonia: Prognostic significance of cellular and fibrosing patterns: Survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 2000; 24: 19–33
   PubMed Web of Science ®Google Scholar
• Daniil ZD, Gilchrist FC, Nicholson AG, Hansell DM, Harris J, Colby TV, et al. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1999; 160: 899–905
   PubMed Web of Science ®Google Scholar
• Schwarz MI, Matthay RA, Sahn SA, Stanford RE, Marmorstein BL, Scheinhorn DJ. Interstitial lung disease in polymyositis and dermatomyositis: Analysis of six cases and review of the literature. Medicine (Baltimore) 1976; 55: 89–104
   PubMed Web of Science ®Google Scholar
• Plowman PN, Stableforth DE. Dermatomyositis with fibrosing alveolitis: Response to treatment with cyclophosphamide. Proc R Soc Med 1977; 70: 738–740
   PubMedGoogle Scholar
• al Janadi M, Smith CD, Karsh J. Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis. J Rheumatol 1989; 16: 1592–1596
   PubMed Web of Science ®Google Scholar
• Maccioni FJ, Colebatch HJ. Management of fibrosing alveolitis with polymyositis dermatomyositis. Aust N Z J Med 1990; 20: 806–810
   PubMedGoogle Scholar
• Rowen AJ, Reichel J. Dermatomyositis with lung involvement, successfully treated with azathioprine. Respiration 1983; 44: 143–146
   PubMed Web of Science ®Google Scholar
• Gruhn WB, Diaz-Buxo JA. Cyclosporine treatment of steroid resistant interstitial pneumonitis associated with dermatomyositis/polymyositis. J Rheumatol 1987; 14: 1045–1047
   PubMed Web of Science ®Google Scholar
• Maeda K, Kimura R, Komuta K, Igarashi T. Cyclosporine treatment for polymyositis/dermatomyositis: Is it possible to rescue the deteriorating cases with interstitial pneumonitis?. Scand J Rheumatol 1997; 26: 24–29
   PubMed Web of Science ®Google Scholar
• Sauty A, Rochat T, Schoch OD, Hamacher J, Kurt AM, Dayer JM, et al. Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies. Eur Respir J 1997; 10: 2907–2912
   PubMed Web of Science ®Google Scholar
• Kurasawa K, Nawata Y, Takabayashi K, Kumano K, Kita Y, Takiguchi Y, et al. Activation of pulmonary T-cells in corticosteroid-resistant and -sensitive interstitial pneumonitis in dermatomyositis/polymyositis. Clin Exp Immunol 2002; 129: 541–548
   PubMed Web of Science ®Google Scholar
• Berman JS, Beer DJ, Theodore AC, Kornfeld H, Bernardo J, Center DM. Lymphocyte recruitment to the lung. Am Rev Respir Dis 1990; 142: 238–257
   PubMed Web of Science ®Google Scholar
• Gill JG, Daniele RP. Morphology of the lung's immune system. Immunology and immunologic diseases of the lung, RP Daniele. Blackwell Scientific Publishers, Boston 1988
   Google Scholar
• Duncan PE, Griffin JP, Garcia A, Kaplan SB. Fibrosing alveolitis in polymyositis. A review of histologically confirmed cases. Am J Med 1974; 57: 621–626
   PubMed Web of Science ®Google Scholar
• Yamadori I, Fujita J, Kajitani H, Bandoh S, Tokuda M, Ohtsuki Y, et al. Lymphocyte subsets in lung tissues of interstitial pneumonia associated with untreated polymyositis/dermatomyositis. Rheumatol Int 2001; 21: 89–93
   PubMed Web of Science ®Google Scholar
• Kourakata H, Takada T, Suzuki E, Enomoto K, Saito I, Taguchi Y, et al. Flowcytometric analysis of bronchoalveolar lavage fluid cells in polymyositis/dermatomyositis with interstitial pneumonia. Respirology. 1999; 4: 223–228
   PubMedGoogle Scholar
• Majumdar S, Li D, Ansari T, Pantelidis P, Black CM, Gizycki M, et al. Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: A quantitative study of open lung biopsies. Eur Respir J 1999; 14: 251–257
   PubMed Web of Science ®Google Scholar
• Ando M, Miyazaki E, Fukami T, Kumamoto T, Tsuda T. Interleukin-4-producing cells in idiopathic pulmonary fibrosis: An immunohistochemical study. Respirology 1999; 4: 383–391
   PubMedGoogle Scholar
• Atamas SP, Yurovsky VV, Wise R, Wigley FM, Goter Robinson CJ, Henry P, et al. Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis. Arthritis Rheum 1999; 42: 1168–1178
   PubMed Web of Science ®Google Scholar
• Enelow RI, Mohammed AZ, Stoler MH, Liu AN, Young AS, Lou YH, et al. Structural and functional consequences of alveolar cell recognition by CD8(+) T lymphocytes in experimental lung disease. J Clin Invest 1998; 102: 1653–1661
   PubMed Web of Science ®Google Scholar
• Clark JG, Madtes DK, Hackman RC, Chen W, Cheever MA, Martin PJ. Lung injury induced by alloreactive Th1 cells is characterized by host-derived mononuclear cell inflammation and activation of alveolar macrophages. J Immunol 1998; 161: 1913–1920
   PubMed Web of Science ®Google Scholar
• Zhao MQ, Foley MP, Stoler MH, Enelow RI. Alveolar epithelial cell chemokine expression induced by specific antiviral CD8+ T-cell recognition plays a critical role in the perpetuation of experimental interstitial pneumonia. Chest 2001; 120: 11S–13S
   Web of Science ®Google Scholar
• Yurovsky VV, Wigley FM, Wise RA, White B. Skewing of the CD8+ T-cell repertoire in the lungs of patients with systemic sclerosis. Hum Immunol 1996; 48: 84–97
   PubMed Web of Science ®Google Scholar
• Schumacher HR, Schimmer B, Gordon GV, Bookspan MA, Brogadir S, Dorwart BB. Articular manifestations of polymyositis and dermatomyositis. Am J Med 1979; 67: 287–292
   PubMed Web of Science ®Google Scholar
• Hashimoto K, Robison L, Velayos E, Niizuma K. Dermatomyositis. Electron microscopic, immunologic, and tissue culture studies of paramyxovirus-like inclusions. Arch Dermatol 1971; 103: 120–135
   PubMedGoogle Scholar
• Hashimoto Y, Nawata Y, Kurasawa K, Takabayashi K, Oda K, Mikata A, et al. Investigation of EB virus and cytomegalovirus in rapidly progressive interstitial pneumonitis in polymyositis/dermatomyositis by in situ hybridization and polymerase chain reaction. Clin Immunol Immunopathol 1995; 77: 298–306
   PubMedGoogle Scholar
• Thompson PL, Mackay IR. Fibrosing alveolitis and polymyositis. Thorax 1970; 25: 504–507
   PubMed Web of Science ®Google Scholar
• Webb DR, Currie GD. Pulmonary fibrosis masking polymyositis. Remission with corticosteroid therapy. JAMA 1972; 222: 1146–1149
   PubMed Web of Science ®Google Scholar
• Takizawa H, Shiga J, Moroi Y, Miyachi S, Nishiwaki M, Miyamoto T. Interstitial lung disease in dermatomyositis: Clinicopathological study. J Rheumatol 1987; 14: 102–107
   PubMed Web of Science ®Google Scholar
• Howard OM, Dong HF, Yang D, Raben N, Nagaraju K, Rosen A, et al. Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells. J Exp Med 2002; 196: 781–791
   PubMed Web of Science ®Google Scholar
• Handschumacher RE, Harding MW, Rice J, Drugge RJ, Speicher DW. Cyclophilin: A specific cytosolic binding protein for cyclosporin A. Science 1984; 226: 544–547
   PubMed Web of Science ®Google Scholar
• Nawata Y, Kurasawa K, Takabayashi K, Miike S, Watanabe N, Hiraguri M, et al. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: Prediction and treatment with cyclosporine. J Rheumatol 1999; 26: 1527–1533
   PubMed Web of Science ®Google Scholar
• Harigai M, Hara M, Kamatani N, Kashiwazaki S. Nation-wide survey for the treatment with cyclosporin A of interstitial pneumonia associated with collagen diseases. Ryumachi 1999; 39: 819–828
   PubMedGoogle Scholar
• Nagasaka K, Harigai M, Tateishi M, Hara M, Yoshizawa Y, Koike T, et al. Efficacy of combination treatment with cyclosporin A and corticosteroids for acute interstitial pneumonitis associated with dermatomyositis. Mod Rheumatol 2003; 13: 231–238
   PubMedGoogle Scholar
• Ishii Y, Kitamura S. The effect of a neutrophil elastase inhibitor ONO5046 for idiopathic interstitial pneumonia. 1997; 43–47, Phase II study. In: Annual Report of the Ministry of Health and Welfare, Diffuse Pulmonary Disease Research Committee
   Google Scholar
• Dumont FJ. FK506, an immunosuppressant targeting calcineurin function. Curr Med Chem 2000; 7: 731–748
   PubMed Web of Science ®Google Scholar
• Liu J, Farmer JD, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991; 66: 807–815
   PubMed Web of Science ®Google Scholar
• Siekierka JJ, Hung SH, Poe M, Lin CS, Sigal NH. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature 1989; 341: 755–757
   PubMed Web of Science ®Google Scholar
• Ochiai T, Nakajima K, Sakamoto K, Nagata M, Gunji Y, Asano T, et al. Comparative studies on the immunosuppressive activity of FK506, 15-deoxyspergualin, and cyclosporine. Transplant Proc 1989; 21: 829–832
   PubMed Web of Science ®Google Scholar
• Kondo H, Abe T, Hashimoto H, Uchida S, Irimajiri S, Hara M, et al. Efficacy and safety of tacrolimus (FK506) in treatment of rheumatoid arthritis: A randomized, double blind, placebo controlled dose-finding study. J Rheumatol 2004; 31: 243–251
   PubMed Web of Science ®Google Scholar
• Yocum DE, Furst DE, Kaine JL, Baldassare AR, Stevenson JT, Borton MA, et al. Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: A double-blind trial. Arthritis Rheum 2003; 48: 3328–3337
   PubMed Web of Science ®Google Scholar
• Kremer JM, Habros JS, Kolba KS, Kaine JL, Borton MA, Mengle-Gaw LJ, et al. Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: A six-month, open-label study. Arthritis Rheum 2003; 48: 2763–2768
   PubMed Web of Science ®Google Scholar
• Furst DE, Saag K, Fleischmann MR, Sherrer Y, Block JA, Schnitzer T, et al. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: A six-month, double-blind, randomized, dose-ranging study. Arthritis Rheum 2002; 46: 2020–2028
   PubMed Web of Science ®Google Scholar
• Oddis CV, Sciurba FC, Elmagd KA, Starzl TE. Tacrolimus in refractory polymyositis with interstitial lung disease. Lancet 1999; 353: 1762–1763
   PubMed Web of Science ®Google Scholar
• Wilkes M, Sereika S, Fertig N, Lucas M, Perez A, Oddis C. Treatment of antisynthetase associated interstitial lung disease with tacrolimus in patients with idiopathic inflammatory myopathy. Arthritis Rheum 2003; 48: S434
   Google Scholar
• Kobayashi J, Kitamura S. KL-6: A serum marker for interstitial pneumonia. Chest 1995; 108: 311–315
   PubMed Web of Science ®Google Scholar
• Nakajima H, Harigai M, Hara M, Hakoda M, Tokuda H, Sakai F, et al. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases. J Rheumatol 2000; 27: 1164–1170
   PubMed Web of Science ®Google Scholar
• Bandoh S, Fujita J, Ohtsuki Y, Ueda Y, Hojo S, Tokuda M, et al. Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis/dermatomyositis. Ann Rheum Dis 2000; 59: 257–262
   PubMed Web of Science ®Google Scholar
• Hugh-Jones P, Lambert AV. A simple standard exercise test and its use for measuring exertion dyspnoea. Br Med J 1952; 1: 65–71
   PubMed Web of Science ®Google Scholar
• Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138: 720–723
   PubMed Web of Science ®Google Scholar